ConductScience.org, home

Paper24668

Factors influencing the therapy of experimental Proteus mirabilis meningitis in rabbits.

Strausbaugh LJ and 1 other. J Infect Dis, 1978. Cited by 104 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Factors influencing the therapy of experimental Proteus mirabilis meningitis in rabbits. Papers, record 24668. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24668

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Factors influencing the therapy of experimental Proteus mirabilis meningitis in rabbits.
PubMed
Journal
J Infect Dis
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
104
iCite
Relative citation ratio, by iCite
5.34
iCite
Revised in PubMed
2019-05-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Strausbaugh LJL J
2Sande MAM A

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MeningitisMajor topic
Proteus InfectionsMajor topic
Animals
Chloramphenicol
Disease Models, Animal
Dose-Response Relationship, Drug
Drug Antagonism
Gentamicins
Hydrogen-Ion Concentration
Rabbits

Source PubMed

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.

PMIDTitleJournalYearIn PapersSource
22,678,778Use of corticosteroids and other adjunct therapies for acute bacterial meningitis in adults.Curr Infect Dis Rep2012https://conductscience.org/library/papers/22678778PubMed
12,818,910Diagnosis and treatment of bacterial meningitis.Arch Dis Child2003https://conductscience.org/library/papers/12818910PubMed
11,735,611Bacterial meningitis: current controversies in approaches to treatment.CNS Drugs2001https://conductscience.org/library/papers/11735611PubMed
9,784,935Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections.Clin Pharmacokinet1998https://conductscience.org/library/papers/9784935PubMed
8,980,753Once-daily gentamicin therapy for experimental Escherichia coli meningitis.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/8980753PubMed
8,586,029Bacterial meningitis. Practical guidelines for management.Drugs1995https://conductscience.org/library/papers/8586029PubMed
7,228,243Current concepts in the treatment of pyogenic meningitis.Indian J Pediatr1980https://conductscience.org/library/papers/7228243PubMed
7,042,759Rapid differentiation of bacterial meningitides by direct gas-liquid chromatography.J Clin Invest1982https://conductscience.org/library/papers/7042759PubMed
7,012,035Deficient cerebrospinal fluid opsonization in experimental Escherichia coli meningitis.Infect Immun1981https://conductscience.org/library/papers/7012035PubMed
6,991,272Scope and limitations of experimental chemotherapy.Experientia1980https://conductscience.org/library/papers/6991272PubMed
6,826,714Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits.J Clin Invest1983https://conductscience.org/library/papers/6826714PubMed
6,396,094Rationale for optimal dosing of beta-lactam antibiotics in therapy for bacterial meningitis.Eur J Clin Microbiol1984https://conductscience.org/library/papers/6396094PubMed
6,386,425Chloramphenicol in the 1980s.Drugs1984https://conductscience.org/library/papers/6386425PubMed
3,195,999Antagonistic effect of chloramphenicol in combination with cefotaxime or ceftriaxone.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3195999PubMed
2,729,936Influence of antibiotic dose, dosing interval, and duration of therapy on outcome in experimental pneumococcal meningitis in rabbits.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2729936PubMed
2,163,241Evaluation of piperacillin-tazobactam in experimental meningitis caused by a beta-lactamase-producing strain of K1-positive Escherichia coli.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2163241PubMed
354,518Comparison of netilmicin with gentamicin in the therapy of experimental Escherichia coli meningitis.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/354518PubMed
228,591Mecillinam-ampicillin synergism in experimental Enterobacteriaceae meningitis.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/228591PubMed
43,705Rosaramicin versus penicillin G in experimental Pneumococcal meningitis.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/43705PubMed
38,742Bactericidal and bacteriostatic action of chloramphenicol against memingeal pathogens.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/38742PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24668

GET https://conductscience.org/api/papers/v1/24668/authors